Sponsor:
Weill Medical College of Cornell University
Code:
NCT06275126
Conditions
Breast Cancer Stage 0
Breast Cancer Stage I
Breast Cancer Stage II
Breast Cancer Stage III
Eligibility Criteria
Sex: Female
Age: 18 - 44
Healthy Volunteers: Not accepted
Interventions
CONSYDER decision aid
Brief summary:
Conditions
Breast Cancer Stage 0
Breast Cancer Stage I
Breast Cancer Stage II
Breast Cancer Stage III
Study ID
NCT06275126
Start date
Mar 13, 2024
Status verified date
Aug, 2026
Completion date
Aug 31, 2027
Anticipated
Primary completion date
May 1, 2027
Anticipated
Eligibility Criteria
Sex: Female
Age: 18 - 44
Healthy Volunteers: Not accepted
Enrollment
800 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Health Services Research
Arms
no intervention: Usual care
other: CONSYDER decision aid
Interventions
CONSYDER decision aid
Primary outcome measure
Central contacts
Locations
Yale Cancer Center
Recruiting
New Haven, Connecticut, United States, 06510
Contacts
Principal Investigator:
Rachel Greenup, MD, MPH
Dana-Farber Cancer Institute
Recruiting
Boston, Massachusetts, United States, 02215
Contacts
Principal Investigator:
Ann Partridge, MD, MPH
Weill Cornell Medicine
Recruiting
New York, New York, United States, 10065
Contacts
Principal Investigator:
Shoshana Rosenberg, ScD, MPH
Duke Cancer Institute
Recruiting
Durham, North Carolina, United States, 27710
Contacts
Principal Investigator:
Jennifer Plichta, MD, MS
Sponsor
Weill Medical College of Cornell University
Last update posted
Aug 19, 2026
Last verified
Aug, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Weill Medical College of Cornell University on 2026-08-19.